United States Angiopoietin 2 Market Report 2018

January 2018 | 100 pages | ID: UD28743EA9DEN
QYResearch

Abstracts

In this report, the United States Angiopoietin 2 market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Angiopoietin 2 in these regions, from 2013 to 2025 (forecast).

United States Angiopoietin 2 market competition by top manufacturers/players, with Angiopoietin 2 sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Amgen Inc.
• AnGes MG, Inc.
• Boehringer Ingelheim GmbH
• Eli Lilly and Company
• F. Hoffmann-La Roche Ltd.
• MedImmune, LLC
• Regeneron Pharmaceuticals, Inc.
• RXi Pharmaceuticals Corporation
• Silence Therapeutics Plc
• Synergys Biotherapeutics, Inc.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Atu-111
• BI-836880
• LY-3127804
• MEDI-3617
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Angiopoietin 2 Market Report 2018

1 ANGIOPOIETIN 2 OVERVIEW

1.1 Product Overview and Scope of Angiopoietin
1.2 Classification of Angiopoietin 2 by Product Category
  1.2.1 United States Angiopoietin 2 Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Angiopoietin 2 Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Atu-111
  1.2.4 BI-836880
  1.2.5 LY-3127804
  1.2.6 MEDI-3617
  1.2.7 Others
1.3 United States Angiopoietin 2 Market by Application/End Users
  1.3.1 United States Angiopoietin 2 Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital
  1.3.3 Clinic
  1.3.4 Others
1.4 United States Angiopoietin 2 Market by Region
  1.4.1 United States Angiopoietin 2 Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Angiopoietin 2 Status and Prospect (2013-2025)
  1.4.3 Southwest Angiopoietin 2 Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Angiopoietin 2 Status and Prospect (2013-2025)
  1.4.5 New England Angiopoietin 2 Status and Prospect (2013-2025)
  1.4.6 The South Angiopoietin 2 Status and Prospect (2013-2025)
  1.4.7 The Midwest Angiopoietin 2 Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Angiopoietin 2 (2013-2025)
  1.5.1 United States Angiopoietin 2 Sales and Growth Rate (2013-2025)
  1.5.2 United States Angiopoietin 2 Revenue and Growth Rate (2013-2025)

2 UNITED STATES ANGIOPOIETIN 2 MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Angiopoietin 2 Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Angiopoietin 2 Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Angiopoietin 2 Average Price by Players/Suppliers (2013-2018)
2.4 United States Angiopoietin 2 Market Competitive Situation and Trends
  2.4.1 United States Angiopoietin 2 Market Concentration Rate
  2.4.2 United States Angiopoietin 2 Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Angiopoietin 2 Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ANGIOPOIETIN 2 SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Angiopoietin 2 Sales and Market Share by Region (2013-2018)
3.2 United States Angiopoietin 2 Revenue and Market Share by Region (2013-2018)
3.3 United States Angiopoietin 2 Price by Region (2013-2018)

4 UNITED STATES ANGIOPOIETIN 2 SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Angiopoietin 2 Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Angiopoietin 2 Revenue and Market Share by Type (2013-2018)
4.3 United States Angiopoietin 2 Price by Type (2013-2018)
4.4 United States Angiopoietin 2 Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ANGIOPOIETIN 2 SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Angiopoietin 2 Sales and Market Share by Application (2013-2018)
5.2 United States Angiopoietin 2 Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ANGIOPOIETIN 2 PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Amgen Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Angiopoietin 2 Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Amgen Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 AnGes MG, Inc.
  6.2.2 Angiopoietin 2 Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 AnGes MG, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Boehringer Ingelheim GmbH
  6.3.2 Angiopoietin 2 Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Boehringer Ingelheim GmbH Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Eli Lilly and Company
  6.4.2 Angiopoietin 2 Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Eli Lilly and Company Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd.
  6.5.2 Angiopoietin 2 Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 MedImmune, LLC
  6.6.2 Angiopoietin 2 Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 MedImmune, LLC Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Regeneron Pharmaceuticals, Inc.
  6.7.2 Angiopoietin 2 Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 RXi Pharmaceuticals Corporation
  6.8.2 Angiopoietin 2 Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 RXi Pharmaceuticals Corporation Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Silence Therapeutics Plc
  6.9.2 Angiopoietin 2 Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Silence Therapeutics Plc Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Synergys Biotherapeutics, Inc.
  6.10.2 Angiopoietin 2 Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 ANGIOPOIETIN 2 MANUFACTURING COST ANALYSIS

7.1 Angiopoietin 2 Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Angiopoietin

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Angiopoietin 2 Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Angiopoietin 2 Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ANGIOPOIETIN 2 MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Angiopoietin 2 Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Angiopoietin 2 Sales Volume Forecast by Type (2018-2025)
11.3 United States Angiopoietin 2 Sales Volume Forecast by Application (2018-2025)
11.4 United States Angiopoietin 2 Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Angiopoietin
Figure United States Angiopoietin 2 Market Size (K Pcs) by Type (2013-2025)
Figure United States Angiopoietin 2 Sales Volume Market Share by Type (Product Category) in 2017
Figure Atu-111 Product Picture
Figure BI-836880 Product Picture
Figure LY-3127804 Product Picture
Figure MEDI-3617 Product Picture
Figure Others Product Picture
Figure United States Angiopoietin 2 Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Angiopoietin 2 by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Angiopoietin 2 Market Size (Million USD) by Region (2013-2025)
Figure The West Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Angiopoietin 2 Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Angiopoietin 2 Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Angiopoietin 2 Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Angiopoietin 2 Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Angiopoietin 2 Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Angiopoietin 2 Sales Share by Players/Suppliers
Figure 2017 United States Angiopoietin 2 Sales Share by Players/Suppliers
Figure United States Angiopoietin 2 Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Angiopoietin 2 Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Angiopoietin 2 Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Angiopoietin 2 Revenue Share by Players/Suppliers
Figure 2017 United States Angiopoietin 2 Revenue Share by Players/Suppliers
Table United States Market Angiopoietin 2 Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Angiopoietin 2 Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Angiopoietin 2 Market Share of Top 3 Players/Suppliers
Figure United States Angiopoietin 2 Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Angiopoietin 2 Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Angiopoietin 2 Product Category
Table United States Angiopoietin 2 Sales (K Pcs) by Region (2013-2018)
Table United States Angiopoietin 2 Sales Share by Region (2013-2018)
Figure United States Angiopoietin 2 Sales Share by Region (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share by Region in 2017
Table United States Angiopoietin 2 Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Angiopoietin 2 Revenue Share by Region (2013-2018)
Figure United States Angiopoietin 2 Revenue Market Share by Region (2013-2018)
Figure United States Angiopoietin 2 Revenue Market Share by Region in 2017
Table United States Angiopoietin 2 Price (USD/Pcs) by Region (2013-2018)
Table United States Angiopoietin 2 Sales (K Pcs) by Type (2013-2018)
Table United States Angiopoietin 2 Sales Share by Type (2013-2018)
Figure United States Angiopoietin 2 Sales Share by Type (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share by Type in 2017
Table United States Angiopoietin 2 Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Angiopoietin 2 Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Angiopoietin 2 by Type (2013-2018)
Figure Revenue Market Share of Angiopoietin 2 by Type in 2017
Table United States Angiopoietin 2 Price (USD/Pcs) by Types (2013-2018)
Figure United States Angiopoietin 2 Sales Growth Rate by Type (2013-2018)
Table United States Angiopoietin 2 Sales (K Pcs) by Application (2013-2018)
Table United States Angiopoietin 2 Sales Market Share by Application (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share by Application (2013-2018)
Figure United States Angiopoietin 2 Sales Market Share by Application in 2017
Table United States Angiopoietin 2 Sales Growth Rate by Application (2013-2018)
Figure United States Angiopoietin 2 Sales Growth Rate by Application (2013-2018)
Table Amgen Inc. Basic Information List
Table Amgen Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Amgen Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Amgen Inc. Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure Amgen Inc. Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table AnGes MG, Inc. Basic Information List
Table AnGes MG, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure AnGes MG, Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure AnGes MG, Inc. Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure AnGes MG, Inc. Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table Boehringer Ingelheim GmbH Basic Information List
Table Boehringer Ingelheim GmbH Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Boehringer Ingelheim GmbH Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Boehringer Ingelheim GmbH Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure Boehringer Ingelheim GmbH Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table Eli Lilly and Company Basic Information List
Table Eli Lilly and Company Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Eli Lilly and Company Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure Eli Lilly and Company Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table MedImmune, LLC Basic Information List
Table MedImmune, LLC Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure MedImmune, LLC Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure MedImmune, LLC Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure MedImmune, LLC Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table Regeneron Pharmaceuticals, Inc. Basic Information List
Table Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure Regeneron Pharmaceuticals, Inc. Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table RXi Pharmaceuticals Corporation Basic Information List
Table RXi Pharmaceuticals Corporation Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure RXi Pharmaceuticals Corporation Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure RXi Pharmaceuticals Corporation Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table Silence Therapeutics Plc Basic Information List
Table Silence Therapeutics Plc Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Silence Therapeutics Plc Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Silence Therapeutics Plc Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure Silence Therapeutics Plc Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table Synergys Biotherapeutics, Inc. Basic Information List
Table Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Growth Rate (2013-2018)
Figure Synergys Biotherapeutics, Inc. Angiopoietin 2 Sales Market Share in United States (2013-2018)
Figure Synergys Biotherapeutics, Inc. Angiopoietin 2 Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Angiopoietin
Figure Manufacturing Process Analysis of Angiopoietin
Figure Angiopoietin 2 Industrial Chain Analysis
Table Raw Materials Sources of Angiopoietin 2 Major Players/Suppliers in 2017
Table Major Buyers of Angiopoietin
Table Distributors/Traders List
Figure United States Angiopoietin 2 Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Angiopoietin 2 Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Angiopoietin 2 Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Angiopoietin 2 Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Angiopoietin 2 Sales Volume Share Forecast by Region (2018-2025)
Figure United States Angiopoietin 2 Sales Volume Share Forecast by Region (2018-2025)
Figure United States Angiopoietin 2 Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources